Literature DB >> 19671673

Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.

Elena I Deryugina1, Erin M Conn, Andreas Wortmann, Juneth J Partridge, Tatyana A Kupriyanova, Veronica C Ardi, John D Hooper, James P Quigley.   

Abstract

The function of CUB domain-containing protein 1 (CDCP1), a recently described transmembrane protein expressed on the surface of hematopoietic stem cells and normal and malignant cells of different tissue origin, is not well defined. The contribution of CDCP1 to tumor metastasis was analyzed by using HeLa carcinoma cells overexpressing CDCP1 (HeLa-CDCP1) and a high-disseminating variant of prostate carcinoma PC-3 naturally expressing high levels of CDCP1 (PC3-hi/diss). CDCP1 expression rendered HeLa cells more aggressive in experimental metastasis in immunodeficient mice. Metastatic colonization by HeLa-CDCP1 was effectively inhibited with subtractive immunization-generated, CDCP1-specific monoclonal antibody (mAb) 41-2, suggesting that CDCP1 facilitates relatively late stages of the metastatic cascade. In the chick embryo model, time- and dose-dependent inhibition of HeLa-CDCP1 colonization by mAb 41-2 was analyzed quantitatively to determine when and where CDCP1 functions during metastasis. Quantitative PCR and immunohistochemical analyses indicated that CDCP1 facilitated tumor cell survival soon after vascular arrest. Live cell imaging showed that the function-blocking mechanism of mAb 41-2 involved enhancement of tumor cell apoptosis, confirmed by attenuation of mAb 41-2-mediated effects with the caspase inhibitor z-VAD-fmk. Under proapoptotic conditions in vitro, CDCP1 expression conferred HeLa-CDCP1 cells with resistance to doxorubicin-induced apoptosis, whereas ligation of CDCP1 with mAb 41-2 caused additional enhancement of the apoptotic response. The functional role of naturally expressed CDCP1 was shown by mAb 41-2-mediated inhibition of both experimental and spontaneous metastasis of PC3-hi/diss. These findings confirm that CDCP1 functions as an antiapoptotic molecule and indicate that during metastasis CDCP1 facilitates tumor cell survival likely during or soon after extravasation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671673      PMCID: PMC3068911          DOI: 10.1158/1541-7786.MCR-09-0100

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  31 in total

1.  The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151.

Authors:  Andries Zijlstra; John Lewis; Bernard Degryse; Heidi Stuhlmann; James P Quigley
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

Review 2.  Apoptosis: controlled demolition at the cellular level.

Authors:  Rebecca C Taylor; Sean P Cullen; Seamus J Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

3.  The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells.

Authors:  G Tezel; M B Wax
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.

Authors:  Jun-ichiro Ikeda; Tomofumi Oda; Masayoshi Inoue; Takamasa Uekita; Ryuichi Sakai; Meinoshin Okumura; Katsuyuki Aozasa; Eiichi Morii
Journal:  Cancer Sci       Date:  2008-12-11       Impact factor: 6.716

5.  Surface-epitope masking (SEM): an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules.

Authors:  Neil I Goldstein; Paul B Fisher
Journal:  Methods Mol Biol       Date:  2007

6.  The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation.

Authors:  Yien Che Tsai; Arnulfo Mendoza; Jennifer M Mariano; Ming Zhou; Zlatka Kostova; Bo Chen; Timothy Veenstra; Stephen M Hewitt; Lee J Helman; Chand Khanna; Allan M Weissman
Journal:  Nat Med       Date:  2007-11-25       Impact factor: 53.440

7.  Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model.

Authors:  Amara C Siva; Martha A Wild; Richard E Kirkland; Mary Jean Nolan; Bing Lin; Toshiaki Maruyama; Ferda Yantiri-Wernimont; Shana Frederickson; Katherine S Bowdish; Hong Xin
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

8.  Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Authors:  Yasuo Awakura; Eijiro Nakamura; Takeshi Takahashi; Hirokazu Kotani; Yoshiki Mikami; Tadashi Kadowaki; Akira Myoumoto; Hideo Akiyama; Noriyuki Ito; Toshiyuki Kamoto; Toshiaki Manabe; Hitoshi Nobumasa; Gozoh Tsujimoto; Osamu Ogawa
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-16       Impact factor: 4.553

9.  CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.

Authors:  Takamasa Uekita; Masamitsu Tanaka; Misato Takigahira; Yuri Miyazawa; Yukihiro Nakanishi; Yae Kanai; Kazuyoshi Yanagihara; Ryuichi Sakai
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

10.  The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1.

Authors:  Stacy M Alvares; Clarence A Dunn; Tod A Brown; Elizabeth E Wayner; William G Carter
Journal:  Biochim Biophys Acta       Date:  2008-01-26
View more
  35 in total

1.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

2.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.

Authors:  M Cecilia Subauste; Tatyana A Kupriyanova; Erin M Conn; Veronica C Ardi; James P Quigley; Elena I Deryugina
Journal:  Clin Exp Metastasis       Date:  2009-10-20       Impact factor: 5.150

4.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Authors:  C H Benes; G Poulogiannis; L C Cantley; S P Soltoff
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

Review 6.  The chick embryo as an expanding experimental model for cancer and cardiovascular research.

Authors:  Kristin H Kain; James W I Miller; Celestial R Jones-Paris; Rebecca T Thomason; John D Lewis; David M Bader; Joey V Barnett; Andries Zijlstra
Journal:  Dev Dyn       Date:  2013-12-19       Impact factor: 3.780

7.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

8.  Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.

Authors:  Gwendlyn Kollmorgen; Gerhard Niederfellner; Alexander Lifke; Gloria J Spohn; Natascha Rieder; Suzana Vega Harring; Frieder Bauss; Helmut Burtscher; Reiner Lammers; Birgit Bossenmaier
Journal:  Mol Oncol       Date:  2013-09-03       Impact factor: 6.603

9.  Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Authors:  Brooke M Emerling; Cyril H Benes; George Poulogiannis; Eric L Bell; Kevin Courtney; Hui Liu; Rayman Choo-Wing; Gary Bellinger; Kazumi S Tsukazawa; Victoria Brown; Sabina Signoretti; Stephen P Soltoff; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-01       Impact factor: 11.205

10.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.